References
Atiq F, Broers AE, Andrews LM, Doorduijn JK, Koch BC, Van Gelder T, Versmissen J (2016) A clinically relevant pharmacokinetic interaction between cyclosporine and imatinib. Eur J Clin Pharmacol 72(6):719–723. doi:10.1007/s00228-016-2038-9
Giebel S, Czyz A, Ottmann O, Baron F, Brissot E, Ciceri F, Cornelissen JJ, Esteve J, Gorin NC, Savani B, Schmid C, Mohty M, Nagler A (2016) Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: a position statement of the acute leukemia working Party of the European Society for blood and marrow transplantation. Cancer. doi:10.1002/cncr.30130
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Atiq, F., Broers, A.E.C., Andrews, L.M. et al. Response: Co-administration of cyclosporine A and imatinib among patients with Philadelphia chromosome-positive leukemias in the post-transplant setting. Eur J Clin Pharmacol 72, 1539–1540 (2016). https://doi.org/10.1007/s00228-016-2123-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-016-2123-0